Related Experiment Video
Updated: Jul 7, 2026

09:08
From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Beta-carboline alkaloids from a Korean tunicate Eudistoma sp
Weihong Wang1, Sang-Jip Nam, Byoung-Chan Lee
1Center for Marine Natural Products and Drug Discovery, School of Earth and Environmental Sciences, Seoul National University, NS-80, Seoul, 151-747, Korea.
Journal of Natural Products
|February 6, 2008
Summary
Seven new beta-carboline compounds, eudistomins Y1-Y7, were discovered in Korean tunicates. Eudistomin Y6 showed moderate antibacterial effects against Gram-positive bacteria without toxicity.
Area of Science:
- Marine Natural Products Chemistry
- Medicinal Chemistry
- Microbiology
Background:
- Tunicates of the genus Eudistoma are a rich source of novel marine metabolites.
- Beta-carboline alkaloids are known for diverse biological activities.
- Marine natural products are crucial for drug discovery.
Purpose of the Study:
- To isolate and characterize new beta-carboline-based metabolites from a Korean Eudistoma tunicate.
- To evaluate the antibacterial potential of the isolated compounds.
Main Methods:
- Isolation and purification of metabolites using chromatographic techniques.
- Structure elucidation of new compounds using spectroscopic methods (NMR, MS).
- Antibacterial activity screening using standard microbiological assays (e.g., MIC).
- Cytotoxicity assessment using MTT assay.
Main Results:
- Seven new beta-carboline derivatives, eudistomins Y1-Y7, were successfully isolated and characterized.
- The new compounds feature a unique benzoyl group at the C-1 position of the beta-carboline nucleus.
- Eudistomin Y6 demonstrated moderate antibacterial activity against Staphylococcus epidermis and Bacillus subtilis.
- Eudistomin Y6 showed no cytotoxicity at 100 microM concentration in the MTT assay.
Conclusions:
- The study expands the chemical diversity of marine beta-carbolines.
- Eudistomin Y6 represents a promising lead compound for developing new antibacterial agents against Gram-positive bacteria.
- Further investigation into the structure-activity relationship of eudistomins is warranted.
